Natural resistance to apoptosis correlates with resistance to chemotherapy in colorectal cancer cells

Clinical and Experimental Medicine

Volumn 12, Issue 2, 2012, Pages 97-103

  Zhang, Yan ^a   Yuan, Jia ^a   Zhang, Hong Yan ^b   Simayi, Dilixia ^a   Li, Pin Dong ^a   Wang, Ying Hong ^a   Li, Feng ^a   Zhang, Wen Jie ^a,c  

^a SHIHEZI UNIVERSITY   (China)

^b Xi'an Center for Disease Control and Prevention   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

5 fluorouracil; Apoptosis; Chemoresistance; Colorectal cancer; Oxaliplatin

Indexed keywords

FLUOROURACIL; OXALIPLATIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER RESISTANCE; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG RESPONSE; HUMAN; HUMAN CELL; MAXIMUM PLASMA CONCENTRATION; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; COLORIMETRY; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; FLUOROURACIL; HUMANS; ORGANOPLATINUM COMPOUNDS; STAINING AND LABELING; TETRAZOLIUM SALTS; THIAZOLES;

EID: 84861478418     PISSN: 15918890     EISSN: 15919528     Source Type: Journal    
DOI: 10.1007/s10238-011-0146-5     Document Type: Article

References (24)

1. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, Blagosklonny MV, El-Deiry WS, Golstein P, Green DR, Hengartner M, Knight RA, Kumar S, Lipton SA, Malorni W, Nunez G, Peter ME, Tschopp J, Yuan J, Piacentini M, Zhivotovsky B, Melino G (2009) Classification of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ 16:3-11
2. Hotchkiss RS, Strasser A, McDunn JE, Swanson PE (2009) Cell death. N Engl J Med 361:1570-1583
3. Huang RS, Ratain MJ (2009) Pharmacogenetics and pharmacogenomics of anticancer agents. CA Cancer J Clin 59:42-55
4. Zhang WJ, Li BH, Yang XZ, Li PD, Yuan Q, Liu XH, Xu SB, Zhang Y, Yuan J, Gerhard GS, Masker KK, Dong C, Koltun WA, Chorney MJ (2008) IL-4-induced Stat6 activities affect apoptosis and gene expression in breast cancer cells. Cytokine 42:39-47
5. Li BH, Yang XZ, Li PD, Yuan Q, Liu XH, Yuan J, Zhang WJ (2008) IL-4/Stat6 activities correlate with apoptosis and metastasis in colon cancer cells. Biochem Biophys Res Commun 69:554-560
6. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74-108 (Pubitemid 40372904)
7. Andre T, Afchain P, Barrier A, Blanchard P, Larsen AK, Tournigand C, Louvet C, de Gramont A (2007) Current status of adjuvant therapy for colon cancer. Gastrointest Cancer Res 1:90-97
8. Andre T, Boni C, Mounedji-Boudiaf L et al (2004) Multicenter international study of oxaliplatin/5-fluorouracil/leucovorin in the adjuvant treatment of colon cancer (MOSAIC) investigators. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350:2343-2351
9. Andre T, Boni C, Navarro M, Tabernero J, Hickish T, Topham C, Bonetti A, Clingan P, Bridgewater J, Rivera F, de Gramont A (2009) Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 27:3109-3116
10. Wyatt MD, Wilson DM 3rd (2009) Participation of DNA repair in the response to 5-fluorouracil. Cell Mol Life Sci 66:788-799
11. Faivre S, Chan D, Salinas R, Woynarowska B, Woynarowski JM (2003) DNA strand breaks and apoptosis induced by oxaliplatin in cancer cells. Biochem Pharmacol 66:225-237 (Pubitemid 36776396)
12. Todd RC, Lippard SJ (2009) Inhibition of transcription by platinum antitumor compounds. Metallomics 1:280-291
13. Melet A, Song K, Bucur O, Jagani Z, Grassian AR, Khosravi-Far R (2008) Apoptotic pathways in tumor progression and therapy. Adv Exp Med Biol 615:47-79
14. Tan TT, White E (2008) Therapeutic targeting of death pathways in cancer: mechanisms for activating cell death in cancer cells. Adv Exp Med Biol 615:81-104
15. Von Hoff DD, Casper J, Bradley E, Sandbach J, Jones D, Makuch R (1981) Association between human tumor colony-forming assay results and response of an individual patient's tumor to chemotherapy. Am J Med 70:1027-1041
16. Kusumoto T, Sakaguchi Y, Maehara Y, Nakashima T, Furusawa M, Sugimachi K (1992) Comparison of in vitro anticancer chemosensitivity between human squamous cell carcinoma and adenocarcinoma. Oncology 49:343-346
17. Sondak VK, Bertelsen CA, Kern DH, Morton DL (1985) Evolution and clinical application of a rapid chemosensitivity assay. Cancer 55:1367-1371 (Pubitemid 15143417)
18. Klumper E, Pieters R, Kaspers GJ, Huismans DR, Loonen AH, Rottier MM, van Wering ER, den Berg A, Hahlen K, Creutzig U, Veerman AJP (1995) In vitro chemosensitivity assessed with the MTT assay in childhood acute non-lymphoblastic leukemia. Leukemia 9:1864-1869
19. Kaspers GJ, Pieters R, Van Zantwijk CH, De Laat PA, De Waal FC, Van Wering ER, Veerman AJ (1991) In vitro drug sensitivity of normal peripheral blood lymphocytes and childhood leukaemic cells from bone marrow and peripheral blood. Br J Cancer 64:469-474
20. Rodriguez-Nieto S, Zhivotovsky B (2006) Role of alterations in the apoptotic machinery in sensitivity of cancer cells to treatment. Curr Pharm Des 12:4411-4425 (Pubitemid 44835154)
21. Grès MC, Julian B, Bourrié M et al (1998) Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line: comparison with the parental Caco-2 cell line. Pharm Res 15:726-733 (Pubitemid 28275649)
22. Drewinko B, Romsdahl MM, Yang LY, Ahearn MJ, Trujillo JM (1976) Establishment of a human carcinoembryonic antigen-producing colon adenocarcinoma cell line. Cancer Res 36(2 Pt 1):467-475
23. Liao QJ, Su J, He J, Song Y, Tang HL, Su Q (2009) Effect of diallyl disulfide on cell cycle arrest of human colon cancer SW480 cells. Ai Zheng (Chin J Cancer) 28:138-141
24. Choi PM, Tchou-Wong KM, Weinstein IB (1990) Overexpression of protein kinase C in HT29 colon cancer cells causes growth inhibition and tumor suppression. Mol Cell Biol 10:4650-4657